Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zaniboni

Showing results (31-40 of 233) with videos related to

Pageof 24
Sort By:
International Journal of Cancer|June 7, 2018
Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?Vincenzo Formica, Alberto Zaniboni, Fotios Loupakis, et al.
Reviews on Recent Clinical Trials|April 25, 2014
The Emerging Role of NRAS Mutations in Colorectal Cancer Patients Selected for Anti-EGFR TherapiesFausto Meriggi, William Vermi, Paola Bertocchi, et al.
Current Drug Safety|August 10, 2012
Oxaliplatin-induced lung toxicity. Case report and review of the literatureTiziana Prochilo, Chiara Abeni, Paola Bertocchi, et al.
BMC Cancer|July 6, 2016
TAS-102, the first "cardio-gentle" fluoropyrimidine in the colorectal cancer landscape?Fausto Petrelli, Sandro Barni, Paola Bertocchi, et al.
Reviews on Recent Clinical Trials|February 27, 2016
QT Prolongation and Anticancer Drugs: Is it a Cardiologist's Worry? The Oncologist's Point of ViewFrancesca Aroldi, Tiziana Prochilo, Elena Bonini, et al.
Tumori|June 6, 2015
That tumor you're going to get tomorrow … maybe: making an informed decisionEnrico Aitini, Francesca Adami, Sandro Barni, et al.
Frontiers in Oncology|November 1, 2023
Optimizing the first-line treatment for metastatic colorectal cancerSara Cherri, Ester Oneda, Laura Zanotti, et al.
Health Policy (Amsterdam, Netherlands)|September 18, 2012
Ethics for end-of-life treatments: metastatic colorectal cancer is one exampleLivio Garattini, Katelijne van de Vooren, Alberto Zaniboni
Reviews on Recent Clinical Trials|July 20, 2013
Chemotherapeutic options for colorectal cancer patients with cardiovascular diseasesBrunella Di Biasi, Tiziana Prochilo, Tony Sabatini, et al.
Reviews on Recent Clinical Trials|August 19, 2015
Prognostic factors after R0 resection of colorectal cancer liver metastases: A systematic review and pooled-analysisFausto Petrelli, Andrea Coinu, Alberto Zaniboni, et al.
Pageof 24

Showing results (31-40 of 233) with videos related to

Sort By:
Pageof 24
International Journal of Cancer|June 7, 2018
Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?Vincenzo Formica, Alberto Zaniboni, Fotios Loupakis, et al.
Reviews on Recent Clinical Trials|April 25, 2014
The Emerging Role of NRAS Mutations in Colorectal Cancer Patients Selected for Anti-EGFR TherapiesFausto Meriggi, William Vermi, Paola Bertocchi, et al.
Current Drug Safety|August 10, 2012
Oxaliplatin-induced lung toxicity. Case report and review of the literatureTiziana Prochilo, Chiara Abeni, Paola Bertocchi, et al.
BMC Cancer|July 6, 2016
TAS-102, the first "cardio-gentle" fluoropyrimidine in the colorectal cancer landscape?Fausto Petrelli, Sandro Barni, Paola Bertocchi, et al.
Reviews on Recent Clinical Trials|February 27, 2016
QT Prolongation and Anticancer Drugs: Is it a Cardiologist's Worry? The Oncologist's Point of ViewFrancesca Aroldi, Tiziana Prochilo, Elena Bonini, et al.
Tumori|June 6, 2015
That tumor you're going to get tomorrow … maybe: making an informed decisionEnrico Aitini, Francesca Adami, Sandro Barni, et al.
Frontiers in Oncology|November 1, 2023
Optimizing the first-line treatment for metastatic colorectal cancerSara Cherri, Ester Oneda, Laura Zanotti, et al.
Health Policy (Amsterdam, Netherlands)|September 18, 2012
Ethics for end-of-life treatments: metastatic colorectal cancer is one exampleLivio Garattini, Katelijne van de Vooren, Alberto Zaniboni
Reviews on Recent Clinical Trials|July 20, 2013
Chemotherapeutic options for colorectal cancer patients with cardiovascular diseasesBrunella Di Biasi, Tiziana Prochilo, Tony Sabatini, et al.
Reviews on Recent Clinical Trials|August 19, 2015
Prognostic factors after R0 resection of colorectal cancer liver metastases: A systematic review and pooled-analysisFausto Petrelli, Andrea Coinu, Alberto Zaniboni, et al.
Pageof 24